Takeshi Kiyoi
Papers
1
Total Citations
23
H-Index
1
About
Dr. Takeshi Kiyoi is a leading researcher in prostate cancer biology, with a particular focus on the role of prostate-specific membrane antigen (PSMA) in tumor progression and metastasis. His most cited work (2021, 23 citations) provides groundbreaking insights into how PSMA-positive membranes secreted from prostate cancer cells can transform vascular endothelial cells into an angiogenic state, revealing a novel mechanism by which tumors promote blood vessel formation. This discovery has significant implications for understanding cancer spread and developing targeted therapies. Dr. Kiyoi's research bridges molecular oncology and vascular biology, demonstrating how tumor-derived extracellular vesicles actively remodel the tumor microenvironment. His work has been instrumental in advancing the clinical utility of 68Ga-PSMA PET/CT as a diagnostic tool for detecting poorly differentiated and castration-resistant prostate cancers. By elucidating the functional role of PSMA beyond its established imaging applications, Dr. Kiyoi has opened new avenues for therapeutic intervention in aggressive prostate cancer. His contributions continue to shape our understanding of tumor-host interactions and inform the development of next-generation cancer diagnostics and treatments.
Research Focus
Key Achievements
Top Papers
- 1